An Update on Stem Cell Therapy for Retinal Diseases

Current clinical trials show promise for a variety of conditions.

By Samuel R. Feldman, MD, Glenn C. Yiu, MD, PhD, Susanna S. Park, MD, PhD

Home Monitoring for Neovascular AMD Conversion

Trends are taking shape that could change retina care.

By SIDNEY A. SCHECHET, MD

Polymers for Retinal Drug Delivery

Sustained-release technologies have the potential to effectively deliver therapeutics to targeted tissues of the eye.

By Charles D. Blizzard, Dina Akasheh, PhD, Matthew Cheung, PharmD, et al.

Replacing the Dilated Fundus Exam With Ultrawidefield Imaging in Asymptomatic Patients

Imaging without dilation may be the future in select patients.

By Angela S. Li, MD, Sharon Fekrat, MD, FASRS

Virtual Reality in Retina

New technologies create new opportunities for retina specialists.

By S.K. Steven Houston, III, MD

Big Data and Data Analytics in Retina

New tools benefit practice management and patient care.

By Elysse Tom, MD, Sabin Dang, MD

UPFRONT: The Future of Technology in Retina

By Peter K. Kaiser, MD

CODING Q&A: Minor Surgery but Not Minor Documentation

To avoid payment denials, make sure your chart notes include the "how" and "why" of each procedure.

By Brandy H. Sperry, COMT, COE, CPC, CPMA

UVEITIS CORNER: Research on Uveitis in Survivors of Ebola Virus Disease

Two uveitis specialists share their experiences.

By Jessica Shantha, MD, Steven Yeh, MD

NEW PRODUCT APPLICATIONS: The First Drug to Treat Geographic Atrophy Debuts

Medication slows the progression of the disease.

By Karen Appold, contributing writer

Clinical Trial Update May 2023

SUBSPECIALTY NEWS: Retina changes seen in Alzheimer disease, research into new GA therapies, and more.

By Rochelle Nataloni, contributing writer